HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
Previous close
$77.05
Day range
$74.11 - $83.78
Year range
$10.81 - $83.78
Market cap
1.13B USD
Avg Volume
478.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.30M | 1,200.00% |
Operating expense | 27.11M | -79.43% |
Net income | -28.65M | -101.54% |
Net profit margin | -2.20K | -100.12% |
Earnings per share | -1.85 | — |
EBITDA | -26.73M | 83.34% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 186.57M | -17.76% |
Total assets | 212.12M | -17.92% |
Total liabilities | 143.56M | 267.61% |
Total equity | 68.56M | — |
Shares outstanding | 14.49M | — |
Price to book | 16.26 | — |
Return on assets | -30.11% | — |
Return on capital | -36.39% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -28.65M | -101.54% |
Cash from operations | -29.95M | 47.78% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -29.95M | -16.90% |
Free cash flow | -20.45M | 64.80% |
About
Founded
2024
Headquarters
Website
Employees
159
